Codexis Inc.

NASDAQ:CDXS  
20.95
-0.26 (-1.23%)
Positive Earnings Pre-Announcement

Codexis Raises 2021 Guidance Following Receipt Of Significant New Order For A Proprietary Enzyme Product

Published: 06/17/2021 20:59 GMT
Codexis Inc. (CDXS) - Codexis Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary Enzyme Product.
Raising Its 2021 Guidance for Total Revenues to a Range of $89 Million to $93 Million.
FY2021 Revenue View $83.7 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $18.05 Million
Adjusted EPS is expected to be -$0.18

Next Quarter Revenue Guidance is expected to be $25.25 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.